Articles référencés

 739 articles référencés cette semaine

Shire saga smells of over​adventurous engineering

It is not obvious that Takeda or Allergan can make the takeover numbers (...)

It is not obvious that Takeda or Allergan can make the takeover numbers work Roll up, roll up, who wants to buy Shire? The FTSE 100 pharmaceutical company, itself built by acquisitions, is (...)

 19/04/2018